-
Je něco špatně v tomto záznamu ?
Coated pellets with delayed-release glucose for prevention of hypoglycemic episodes
D Sabadkova, A Franc, J Muselik, D Neumann
Jazyk angličtina Země Chorvatsko
Grantová podpora
NT14479
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Directory of Open Access Journals
od 2007
Free Medical Journals
od 2003
ProQuest Central
od 2007-03-01
Open Access Digital Library
od 2007-02-28
Open Access Digital Library
od 2007-01-01
Health & Medicine (ProQuest)
od 2007-03-01
Sciendo
od 2007-02-28
ROAD: Directory of Open Access Scholarly Resources
od 1997
PubMed
27279068
DOI
10.1515/acph-2016-0017
Knihovny.cz E-zdroje
- MeSH
- celulosa analogy a deriváty chemie MeSH
- glukosa aplikace a dávkování chemie MeSH
- hypoglykemie krev prevence a kontrola MeSH
- kinetika MeSH
- krevní glukóza metabolismus účinky léků MeSH
- léky s prodlouženým účinkem MeSH
- lidé MeSH
- membrány umělé MeSH
- pomocné látky chemie MeSH
- povrchové vlastnosti MeSH
- příprava léků MeSH
- rozpustnost MeSH
- škrob chemie MeSH
- vysokoúčinná kapalinová chromatografie MeSH
- Check Tag
- lidé MeSH
Patients tend to prevent hypoglycemia by excessive saccharide intake leading to poorer glycemic control with potentially fatal consequences. This problem could be resolved by means of pellets with glucose release delayed by 120-360 min as a compensation of the antidiabetic drug peak effect. No glucose is released before; hence there is no risk of hyperglycemia and secondary complications. The pellets contain glucose in combination with an osmotically active ingredient and are coated with an ethylcellulose dispersion, which forms an insoluble semipermeable membrane and ensures delayed release. The release of glucose was assessed using dissolution and high-performance liquid chromatography. Dissolution profiles indicated the possibility of achieving the requested lag time using a combination of adequate compositions and coating concentrations. Lag times of 60, 240 and 360 min were achieved. The sample containing carboxymethyl starch was found to be most suitable for the intent of this work.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19017605
- 003
- CZ-PrNML
- 005
- 20220411144630.0
- 007
- ta
- 008
- 190517s2016 ci f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1515/acph-2016-0017 $2 doi
- 035 __
- $a (PubMed)27279068
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ci
- 100 1_
- $a Sabadková, Dana $7 _AN080394 $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Czech Republic.
- 245 10
- $a Coated pellets with delayed-release glucose for prevention of hypoglycemic episodes / $c D Sabadkova, A Franc, J Muselik, D Neumann
- 520 9_
- $a Patients tend to prevent hypoglycemia by excessive saccharide intake leading to poorer glycemic control with potentially fatal consequences. This problem could be resolved by means of pellets with glucose release delayed by 120-360 min as a compensation of the antidiabetic drug peak effect. No glucose is released before; hence there is no risk of hyperglycemia and secondary complications. The pellets contain glucose in combination with an osmotically active ingredient and are coated with an ethylcellulose dispersion, which forms an insoluble semipermeable membrane and ensures delayed release. The release of glucose was assessed using dissolution and high-performance liquid chromatography. Dissolution profiles indicated the possibility of achieving the requested lag time using a combination of adequate compositions and coating concentrations. Lag times of 60, 240 and 360 min were achieved. The sample containing carboxymethyl starch was found to be most suitable for the intent of this work.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a krevní glukóza $x metabolismus $x účinky léků $7 D001786
- 650 02
- $a celulosa $x analogy a deriváty $x chemie $7 D002482
- 650 02
- $a vysokoúčinná kapalinová chromatografie $7 D002851
- 650 02
- $a léky s prodlouženým účinkem $7 D003692
- 650 02
- $a příprava léků $7 D004339
- 650 02
- $a pomocné látky $x chemie $7 D005079
- 650 02
- $a glukosa $x aplikace a dávkování $x chemie $7 D005947
- 650 02
- $a lidé $7 D006801
- 650 02
- $a hypoglykemie $x krev $x prevence a kontrola $7 D007003
- 650 02
- $a kinetika $7 D007700
- 650 02
- $a membrány umělé $7 D008567
- 650 02
- $a rozpustnost $7 D012995
- 650 02
- $a škrob $x chemie $7 D013213
- 650 02
- $a povrchové vlastnosti $7 D013499
- 650 02
- $a Technology, Pharmaceutical $x mt [Methods]
- 650 02
- $a Water $x ch [Chemistry]
- 700 1_
- $a Franc, Aleš, $d 1968- $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Czech Republic. $7 mzk2008479726
- 700 1_
- $a Muselík, Jan $7 xx0100243 $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Czech Republic.
- 700 1_
- $a Neumann, David, $q University Hospital, Department of Pediatrics, Hradec Králové. Czech Republic $d 1973- $7 xx0079752
- 773 0_
- $t Acta Pharmaceutica $g Roč. 66, č. 2 (2016), s. 257-267 $p ACTA PHARM. $x 1330-0075 $w MED00000116
- 773 0_
- $p ACTA PHARM. $g 66(2):257-67, 2016 Jun 01
- 910 __
- $a ABA008 $y 4 $z 0
- 990 __
- $a 20190517111255 $b ABA008
- 991 __
- $a 20220411144628 $b ABA008
- 999 __
- $a ok $b bmc $g 1405653 $s 1056806
- BAS __
- $a 3
- BMC __
- $a 2016 $b 66 $c 2 $d 257-267 $x MED00000116 $i 1330-0075 $m Acta pharmaceutica
- GRA __
- $a NT14479 $p MZ0
- LZP __
- $a NLK 2019/lp